JOHNSON & JOHNSON
CIK
200406
Location
NEW BRUNSWICK, NJ
Portfolio Value
Small
$648,749,737
Diversification
Highly concentrated
Filing Date
Global Rank
#2,274
/ 8,588
▲ 249
Top Industry
Biotechnology
92.7%
3Y Alpha vs SPY
+10.2%
Period ended 3 months ago
Filed May 13, 2026 · 35d
19 quarters · since Sep 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+127.1%
SPY
+78.1%
Annualised alpha
+10.2%
Max drawdown
−43.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
15 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
39.8%
+0.8 pts
Top 5
89.9%
+2.6 pts
Top 10
99.5%
+0.2 pts
HHI
2,512
Highly concentrated+182
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $648,749,737 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| NNOX | Nano-X Imaging Ltd. | −75,298 | 83,554 | $189,667 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| RLYB | Rallybio Corp | 152,901 | $1,371,521 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | 54,887 | $1,689,421 | |
| No positions match the current search. | ||||
15 positions ·
$648,749,737 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ACET |
Adicet Bio, Inc.
Healthcare
|
Held | 22,779 | $155,124 | 0.02% | |
| NNOX |
Nano-X Imaging Ltd.
Healthcare
|
Reduced | 83,554 | $189,667 | 0.03% | |
| LAB |
Standard Biotools Inc.
Healthcare
|
Held | 311,967 | $287,009 | 0.04% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 53,732 | $958,578 | 0.15% | |
| RLYB |
Rallybio Corp
Healthcare
|
NEW | 152,901 | $1,371,521 | 0.21% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
Held | 3,379,064 | $4,054,876 | 0.63% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
Held | 357,939 | $8,952,054 | 1.38% | |
| XNCR |
Xencor Inc
Healthcare
|
Held | 748,062 | $9,021,627 | 1.39% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Held | 814,586 | $14,735,860 | 2.27% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Held | 1,979,173 | $25,847,999 | 3.98% | |
| CVRX |
CVRx, Inc.
Healthcare
|
Reduced | 4,024,861 | $38,075,185 | 5.87% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 1,784,517 | $55,837,536 | 8.61% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Held | 6,641,064 | $57,511,614 | 8.86% | |
| NBTX |
Nanobiotix S.A.
Healthcare
|
Held | 5,623,816 | $173,607,199 | 26.76% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 2,449,183 | $258,143,888 | 39.79% |